<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02159898</url>
  </required_header>
  <id_info>
    <org_study_id>ESO-P3-12-02</org_study_id>
    <nct_id>NCT02159898</nct_id>
  </id_info>
  <brief_title>EndoMAXX EVT Compared to EndoMAXX</brief_title>
  <official_title>Prospective, Multicenter, Single Blind, Randomized Study Comparing the EndoMAXX EVT Fully Covered Esophageal Stent With Valve to the EndoMAXX Fully Covered Esophageal Stent for Malignant Strictures Requiring Stent Placement Across the Gastroesophageal Junction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merit Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Geisinger Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Merit Medical Systems, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single blinded, randomized study of EndoMAXX EVT Fully Covered
      Esophageal Stent with Valve for the treatment of malignant strictures of the lower esophagus.
      The purpose of this study is to evaluate improvement of dysphagia due to esophageal stricture
      with EndoMAXX EVT Fully Covered Esophageal Stent with Valve (investigational device) compared
      to the EndoMAXX Fully Covered Esophageal Stent (reference device).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mellow and Pinkas Dysphagia Score</measure>
    <time_frame>2 Weeks Following Treatment</time_frame>
    <description>The primary endpoint is to evaluate improvement of dysphagia due to esophageal strictures at 2 weeks following treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>GERD-HRQL</measure>
    <time_frame>4 Weeks Following Treament</time_frame>
    <description>Evaluate symptoms of gastric reflux as assessed by Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) instrument at 4 weeks following treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regurgitation Questionnaire</measure>
    <time_frame>4 Weeks Following Treatment</time_frame>
    <description>Assess symptoms of regurgitation using a regurgitation questionnaire at 4 weeks following treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>6 Months</time_frame>
    <description>Assess the incidence of stent migration resulting in non-performance of the stent, food impaction, and esophageal perforation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Malignant Esophageal Strictures</condition>
  <arm_group>
    <arm_group_label>EndoMAXX EVT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EndoMAXX EVT Fully Covered Esophageal Stent with Valve</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EndoMAXX</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EndoMAXX Fully Covered Esophageal Stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EndoMAXX EVT</intervention_name>
    <arm_group_label>EndoMAXX EVT</arm_group_label>
    <other_name>EndoMAXX EVT Fully Covered Esophageal Stent with Valve</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EndoMAXX</intervention_name>
    <arm_group_label>EndoMAXX</arm_group_label>
    <other_name>EndoMAXX Fully Covered Esophageal Stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is 18 years of age or older

          2. Patient (or legal representative) is able to understand and provide signed informed
             consent

          3. Patient has a malignant stricture of the distal esophagus or gastric cardia requiring
             stent placement across the gastroesophageal junction.

        Exclusion Criteria:

          1. Patient is unwilling or unable to comply with the follow-up schedule

          2. Patient is contraindicated for endoscopic procedure for any reason

          3. Patient presents with esophagorespiratory fistula

          4. Patient has previously undergone esophageal stenting or esophagectomy

          5. Female patient is pregnant, breastfeeding, or premenopausal and not using an effective
             method of contraception

          6. Patient's esophageal tumor length exceeds that which can be treated with a single
             stent (maximum lesion length 9.5cm)

          7. Removal of stent is scheduled to occur within six months

          8. Patient has trouble swallowing or experiences regurgitation for reasons which are not
             related to his/her esophageal cancer

          9. Any other factor identified by the Investigator that would disqualify the prospective
             patient from participation in the study including but not limited to coagulative
             disorders and anesthetic risk.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kulwinder DUA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of WI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainsville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2014</study_first_submitted>
  <study_first_submitted_qc>June 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2014</study_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Esophageal Cancer</keyword>
  <keyword>Dysphagia</keyword>
  <keyword>Regurgitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Esophageal Stenosis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>December 22, 2017</submitted>
    <returned>January 22, 2018</returned>
    <submitted>March 28, 2018</submitted>
    <returned>April 26, 2018</returned>
    <submitted>May 4, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

